Longitudinal monitoring of bone measured by quantitative multisite ultrasound in patients with Crohn's disease

被引:0
|
作者
Zadik, Z [1 ]
Sinai, T
Zung, A
Reifen, R
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Kaplan Med Ctr, Pediat Endocrine Unit, IL-76100 Rehovot, Israel
[2] Hebrew Univ Jerusalem, Sch Nutr Sci, IL-76100 Rehovot, Israel
关键词
Crohn's disease; bone density; oxandrolone;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Crohn's disease (CD) is characterized, among other features, by intestinal malabsorption of minerals, vitamins, and various food ingredients. This may cause a suboptimal peak bone mass and thereby susceptibility to osteoporosis at an early age. Objective: Longitudinal measurement of bone in CD during active disease and during remission. Design: We evaluated 24 patients with CD (16 males) 14 to 16 years of age longitudinally, every 3 months over 12 months, for disease activity. Longitudinal follow-up by quantitative ultrasound measurement using a bone sonometer (Sunlight Omnisense, Tel Aviv, Israel) that obtains axial speed of sound (SOS) was also performed. Eight of the CD patients were in remission (R-CD), characterized by accelerated weight and height gain and near-normal erythrocyte sedimentation rate and serum iron. Eight patients had active CD (A-CD), and 8 patients were under treatment with oxandrolone. Results: By two-way repeated-measures analysis of variance, the change in SOS Z-score of tibia at 0, 6, and 12 months was as follows: -0.5 +/- 0.2 to -0.3 +/- 0.2, -0.6 +/- 0.2 to -1.0 +/- 0. 5 and - 0.6 +/- 0.2 to -0.4 +/- 0.2 in the remission, active disease, and oxandrolone-treated groups, respectively (P < 0.001). Similarly, the change in SOS Z-score of radius during the study was as follows: - 0.5 +/- 0.3 to -0.6 +/- 0.3, -0.6 +/- 0.3 to -1.0 +/- 0.3 and -0.6 +/- 0.2 to -0.4 +/- 0.2 in the remission, active disease, and oxandrolone-treated groups, respectively (P < 0.001). While a small change over time in patients in remission was noted, SOS decreased in patients with active disease and increased in oxandrolone-treated patients. Despite the fact that SOS remained in the normative range in all patients, a clear deterioration was demonstrated for patients with active disease. Conclusions: We conclude that longitudinal follow-up of patients with active disease may detect an early pattern of deterioration in quality of bone.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 50 条
  • [1] Longitudinal monitoring of bone measured by quantitative multisite ultrasound in patients with Crohn's disease
    Zadik, Z
    Sinai, T
    Reifen, R
    BONE, 2005, 36 : S77 - S77
  • [2] Quantitative bone ultrasound measurements in patients with Crohn's disease
    Pereira, SPM
    Barros, JH
    Veloso, T
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S82 - S82
  • [3] Longitudinal study of bone mineral density in patients with Crohn's disease
    De Jong, DJ
    Mannaerts, L
    Van Rossum, LGM
    Corstens, FHM
    Naber, AHJ
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (07) : 1355 - 1359
  • [4] Longitudinal Study of Bone Mineral Density in Patients with Crohn's Disease
    D.J. De Jong
    L. Mannaerts
    L.G.M. van Rossum
    F.H.M. Corstens
    A.H.J. Naber
    Digestive Diseases and Sciences, 2003, 48 : 1355 - 1359
  • [5] Monitoring asymptomatic patients with Crohn's disease: the role of intestinal ultrasound
    Dussias, N.
    Melotti, L.
    Mazzotta, E.
    Decorato, A.
    Vanigli, N.
    Rizzello, F.
    Gionchetti, P.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 837 - 838
  • [6] Impact of prematurity on longitudinal measurement of bone status as measured by quantitative ultrasound
    Pereda, LA
    Ashmeade, T
    Zaritt, J
    Carver, J
    PEDIATRIC RESEARCH, 2003, 53 (04) : 444A - 444A
  • [7] Longitudinal monitoring of bone accretion measured by quantitative multi-site ultrasound (QUS) of bones in patients with delayed puberty (a pilot study)
    Zadik, Z
    Sinai, T
    Borondukov, E
    Zung, A
    Yaniv, I
    Reifen, R
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (09) : 1036 - 1041
  • [8] Longitudinal monitoring of bone accretion measured by quantitative multi-site ultrasound (QUS) of bones in patients with delayed puberty (a pilot study)
    Zvi Zadik
    Tali Sinai
    Ella Borondukov
    Amnon Zung
    Irit Yaniv
    Ram Reifen
    Osteoporosis International, 2005, 16 : 1036 - 1041
  • [9] Crohn′s disease response to ustekinumab measured by bowel ultrasound
    Navarro-Gerrard, C.
    Baston Rey, I.
    Gonzalez Lopez, J.
    Ferreiro Iglesias, R.
    Sequeiros Portela, M. D.
    Dominguez Munoz, J. E.
    Barreiro de Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1710 - I1710
  • [10] MONITORING CROHN'S DISEASE PATIENTS IN CLINICAL REMISSION: THE ROLE OF INTESTINAL ULTRASOUND
    Dussias, Nikolas K.
    Melotti, Laura
    Vanigli, Nicholas
    Mazzotta, Elena
    Rizzello, Fernando
    Gionchetti, Paolo
    GASTROENTEROLOGY, 2024, 166 (05) : S1109 - S1109